Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients’ Perspective

Abstract

Patients with IBD are significantly more affected by the COVID-19 pandemic than their non-IBD peers, but they continue to adhere to their medication regimens. IBD-focused COVID-19 information should be actively conveyed.